V

Vimian Group AB
STO:VIMIAN

Watchlist Manager
Vimian Group AB
STO:VIMIAN
Watchlist
Price: 44 SEK 2.68% Market Closed
Market Cap: 22.7B SEK
Have any thoughts about
Vimian Group AB?
Write Note

Vimian Group AB
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Vimian Group AB
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
V
Vimian Group AB
STO:VIMIAN
Accrued Liabilities
€16.1m
CAGR 3-Years
16%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
O
OssDsign AB
STO:OSSD
Accrued Liabilities
kr32.9m
CAGR 3-Years
33%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Xvivo Perfusion AB
STO:XVIVO
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
D
Doxa AB
STO:DOXA
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bactiguard Holding AB
STO:BACTI B
Accrued Liabilities
kr31m
CAGR 3-Years
57%
CAGR 5-Years
28%
CAGR 10-Years
N/A
S
S2Medical AB (publ)
STO:S2M
Accrued Liabilities
kr2.7m
CAGR 3-Years
3%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

Vimian Group AB
Glance View

Market Cap
23B SEK
Industry
Health Care

Vimian Group AB operates as an animal health company. The company is headquartered in Stockholm, Stockholm and currently employs 1,068 full-time employees. The company went IPO on 2021-06-18. The firm is a parent company of the group of companies operating with a purpose of improving animal health through science and technology. The Group delivers solutions to veterinary professionals, labs and pet parents around the world. The purpose of Vimian Group is to unite companies in selected niches of animal health and help them grow faster. The firm invests in innovation and new technologies to advance veterinary medicine. The Group covers four essential and rapidly evolving areas within animal health: Specialty Pharma, Diagnostics, Veterinary Services and MedTech. Vimian provides individual businesses with access to its networks, advisory services, infrastructure and capital.

VIMIAN Intrinsic Value
46.34 SEK
Undervaluation 5%
Intrinsic Value
Price
V

See Also

What is Vimian Group AB's Accrued Liabilities?
Accrued Liabilities
16.1m EUR

Based on the financial report for Sep 30, 2024, Vimian Group AB's Accrued Liabilities amounts to 16.1m EUR.

What is Vimian Group AB's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
16%

Over the last year, the Accrued Liabilities growth was 5%. The average annual Accrued Liabilities growth rates for Vimian Group AB have been 16% over the past three years .

Back to Top